AVBP
ArriVent BioPharma (AVBP)
$11
About ArriVent BioPharma (AVBP)
Arrivent Biopharma, Inc. is a clinical-stage biopharmaceutical company, which engages in identifying, licensing, and globalizing biopharma innovations from around the world to deliver important medicines to patients. The company was founded Zheng Bin Yao and Stuart Lutzker on April 14, 2021 and is headquartered in Newtown Square, PA.
Details
Daily high
$24.41
Daily low
$22.76
Price at open
--
52 Week High
$29.71
52 Week Low
$15.47
Market cap
975.9M
Dividend yield
0.00%
Volume
477,366
Avg. volume
374,562
P/E ratio
-5.58
ArriVent BioPharma News
Details
Daily high
$24.41
Daily low
$22.76
Price at open
--
52 Week High
$29.71
52 Week Low
$15.47
Market cap
975.9M
Dividend yield
0.00%
Volume
477,366
Avg. volume
374,562
P/E ratio
-5.58